FDA Inspection 1204020 — High Point Regional Health System

High Point Regional Health System — FEI 3008613265

The FDA completed an inspection of High Point Regional Health System on April 26, 2023 in High Point, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 26, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
High Point, NC (United States)